A complete application in a minute
Tailored resume and cover letter, ready to send.
Amgen is seeking a Business Performance Senior Manager to lead the AIN Project Controls Team. You will drive financial discipline, governance, and execution excellence across a portfolio of technology initiatives, partnering with US-based execution teams and senior leadership.
Lead, develop, and standardize project controls, and deliver executive-level reporting. This role requires strategic planning, cross-functional collaboration, and strong finance process ownership within a biotech context.
The Business Performance Senior Manager will lead the AIN Project Controls Team, ensuring financial discipline, project controls governance, and execution excellence across a portfolio of high-impact technology initiatives. This role will drive standardization, talent development, strategic planning, and partnership with senior leadership and U.S.-based execution teams.
Lead and develop project controls professionals across AIN Technology portfolios. Establish best practices, standards, and operating models. Coach and mentor team members and drive capability development. Promote knowledge sharing and continuous improvement.
Ensure fiscal discipline across technology programs. Oversee quarterly close, accruals, forecasts, and budget processes. Ensure compliance with finance policies and SOX requirements. Drive resource optimization and financial performance.
Lead monthly financial reviews and variance analysis. Monitor project financial risks and mitigation activities. Ensure adherence to enterprise project controls standards. Provide executive-level reporting and decision support.
Collaborate with Finance, Procurement, Portfolio Leadership, and US-based stakeholders. Drive cross-functional alignment and issue resolution. Deliver business insights and recommendations to senior executives.
Standardize project controls methodologies. Support workforce planning and resource management. Implement process improvements and reporting enhancements.
Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology. Amgen focuses on areas of high unmet medical need and leverages its biologics manufacturing expertise to strive for solutions that improve health outcomes and dramatically improve people's lives. A biotechnology pioneer since 1980, Amgen has grown to be one of the world's leading independent biotechnology companies, has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential. For more information, visit www.amgen.com and follow us on www.twitter.com/amgen